1,022
Participants
Start Date
November 30, 2010
Primary Completion Date
February 28, 2014
Study Completion Date
June 30, 2014
Custirsen
Docetaxel
Prednisone
Dexamethasone
Dexamethasone 8 mg by mouth twice a day for 3 days beginning one day before docetaxel administration to reduce the incidence and severity of hypersensitivity reactions and fluid retention.
Teva Investigational Site 100, Birmingham
Teva Investigational Site 086, Los Angeles
Teva Investigational Site 263, Los Angeles
Teva Investigational Site 093, Marina del Rey
Teva Investigational Site 097, San Diego
Teva Investigational Site 090, Fort Collins
Teva Investigational Site 106, Fort Myers
Teva Investigational Site 094, Port Saint Lucie
Teva Investigational Site 096, Atlanta
Teva Investigational Site 103, Baton Rough
Teva Investigational Site 098, Ann Arbor
Teva Investigational Site 112, Detroit
Teva Investigational Site 032, Rochester
Teva Investigational Site 204, Las Vegas
Teva Investigational Site 107, Cincinnati
Teva Investigational Site 266, Greensboro
Teva Investigational Site 102, Myrtle Beach
Teva Investigational Site 084, Memphis
Teva Investigational Site 101, Nashville
Teva Investigational Site 116, San Antonio
Teva Investigational Site 059, Tyler
Teva Investigational Site 063, Tyler
Teva Investigational Site 047, Newport
Teva Investigational Site 104, Norfolk
Teva Investigational Site 029, Seattle
Teva Investigational Site 862, Bonheiden
Teva Investigational Site 860, Brussels
Teva Investigational Site 864, Edegem
Teva Investigational Site 863, Ghent
Teva Investigational Site 002, Calgary
Teva Investigational Site 023, Edmonton
Teva Investigational Site 118, Abbotsford
Teva Investigational Site 007, Surrey
Teva Investigational Site 001, Vancouver
Teva Investigational Site 085, Victoria
Teva Investigational Site 024, Winnipeg
Teva Investigational Site 028, Halifax
Teva Investigational Site 025, Hamilton
Teva Investigational Site 108, Kingston
Teva Investigational Site 091, Oshawa
Teva Investigational Site 003, Ottawa
Teva Investigational Site 004, Toronto
Teva Investigational Site 087, Toronto
Teva Investigational Site 026, Montreal
Teva Investigational Site 027, Montreal
Teva Investigational Site 551, Angers
Teva Investigational Site 552, Avignon
Teva Investigational Site 553, Grenoble
Teva Investigational Site 555, La Roche-sur-Yon
Teva Investigational Site 557, Marseille
Teva Investigational Site 558, Nice
Teva Investigational Site 559, Paris
Teva Investigational Site 560, Paris
Teva Investigational Site 566, Saint-Brieuc
Teva Investigational Site 561, Saint-Herblain
Teva Investigational Site 562, Saint-Priest-en-Jarez
Teva Investigational Site 563, Toulouse
Teva Investigational Site 564, Vandœuvre-lès-Nancy
Teva Investigational Site 550, Villejuif
Teva Investigational Site 607, Aachen
Teva Investigational Site 609, Berlin
Teva Investigational Site 613, Berlin
Teva Investigational Site 604, Darmstadt
Teva Investigational Site 612, Dresden
Teva Investigational Site 618, Greifswald
Teva Investigational Site 600, Hanover
Teva Investigational Site 606, Heidelberg
Teva Investigational Site 615, Heinsberg
Teva Investigational Site 611, Homburg/Saar
Teva Investigational Site 617, Kempen
Teva Investigational Site 608, Marburg
Teva Investigational Site 616, Meiningen
Teva Investigational Site 614, München
Teva Investigational Site 601, Münster
Teva Investigational Site 602, Nürtingen
Teva Investigational Site 603, Stuttgart
Teva Investigational Site 610, Tübingen
Teva Investigational Site 605, Wuppertal
Teva Investigational Site 691, Budapest
Teva Investigational Site 694, Budapest
Teva Investigational Site 692, Debrecen
Teva Investigational Site 697, Debrecen
Teva Investigational Site 696, Győr
Teva Investigational Site 698, Miskolc
Teva Investigational Site 699, Nyíregyháza
Teva Investigational Site 693, Szeged
Teva Investigational Site 695, Veszprém
Teva Investigational Site 506, Jerusalem
Teva Investigational Site 507, Haifa
Teva Investigational Site 505, Petah Tikva
Teva Investigational Site 502, Ramat Gan
Teva Investigational Site 503, Tel Aviv
Teva Investigational Site 501, Zrifin
Teva Investigational Site 753, Arezzo
Teva Investigational Site 758, Catanzaro
Teva Investigational Site 760, Cesena (FC)
Teva Investigational Site 752, Genova
Teva Investigational Site 755, Lugo (Ravenna)
Teva Investigational Site 759, Meldola (FC)
Teva Investigational Site 763, Milan
Teva Investigational Site 754, Napoli
Teva Investigational Site 756, Napoli
Teva Investigational Site 761, Rimini
Teva Investigational Site 750, Roma
Teva Investigational Site 762, Roma
Teva Investigational Site 764, Rozzano (MI)
Teva Investigational Site 765, Verona
Teva Investigational Site 851, Amsterdam
Teva Investigational Site 852, Rotterdam
Teva Investigational Site 853, Sittard-Geleen
Teva Investigational Site 404, Cheongju,Chungbuk
Teva Investigational Site 401, Goyang-si Gyeonggi-do
Teva Investigational Site 400, Seoul
Teva Investigational Site 402, Seoul
Teva Investigational Site 403, Seoul
Teva Investigational Site 406, Seoul
Teva Investigational Site 405, Yangsan
Teva Investigational Site 803, Barcelona
Teva Investigational Site 808, Barcelona
Teva Investigational Site 809, Barcelona
Teva Investigational Site 816, Dos Hermanas
Teva Investigational Site 814, El Palmar
Teva Investigational Site 807, Guadalajara
Teva Investigational Site 800, Madrid
Teva Investigational Site 801, Madrid
Teva Investigational Site 806, Madrid
Teva Investigational Site 813, Madrid
Teva Investigational Site 815, Manresa
Teva Investigational Site 810, Murcia
Teva Investigational Site 811, Palma de Mallorca
Teva Investigational Site 805, Pamplona
Teva Investigational Site 804, Sabadell - Barcelona
Teva Investigational Site 802, Valencia
Teva Investigational Site 704, Brighton
Teva Investigational Site 701, Cambridge
Teva Investigational Site 709, Coventry
Teva Investigational Site 705, Guildford, Surrey
Teva Investigational Site 703, Manchester
Teva Investigational Site 710, Metropolitan Borough of Wirral
Teva Investigational Site 700, Surrey
Lead Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
INDUSTRY
Achieve Life Sciences
INDUSTRY